Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - Actinium Pharmaceuticals, Inc. | f10k2015_actiniumpharma.htm |
| EX-31.2 - CERTIFICATION - Actinium Pharmaceuticals, Inc. | f10k2015ex31ii_actinium.htm |
| EX-10.57 - OFFICE SPACE LICENSE AGREEMENT, DATED MARCH 19, 2016, BY AND BETWEEN ACTINIUM PHARMACEUTICALS, INC. AND RELMADA THERAPEUTICS, INC. - Actinium Pharmaceuticals, Inc. | f10k2015ex10lvii_actinium.htm |
| EX-10.56 - THIRD AMENDMENT TO THE 2013 AMENDED AND RESTATED STOCK PLAN, EFFECTIVE AS OF DECEMBER 22, 2015 - Actinium Pharmaceuticals, Inc. | f10k2015ex10xxxxxvi_actinium.htm |
| EX-32.1 - CERTIFICATION - Actinium Pharmaceuticals, Inc. | f10k2015ex32i_actinium.htm |
| EX-21.1 - LIST OF SUBSIDIARIES - Actinium Pharmaceuticals, Inc. | f10k2015ex21i_actinium.htm |
| EX-31.1 - CERTIFICATION - Actinium Pharmaceuticals, Inc. | f10k2015ex31i_actinium.htm |
| EX-32.2 - CERTIFICATION - Actinium Pharmaceuticals, Inc. | f10k2015ex32ii_actinium.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-3 (File No. 333-194768) and Form S-8 (File No. 333-197283) filed with the Securities and Exchange Commission, of our report dated March 11, 2016, relating to the consolidated financial statements of Actinium Pharmaceuticals, Inc. as of December 31, 2015 and 2014 and for each of the three years ended December 31, 2015 and relating to the internal controls over financial reporting for the year ended December 31, 2015, appearing in this Annual Report on Form 10-K of Actinium Pharmaceuticals, Inc.
/s/ GBH CPAs, PC
GBH CPAs, PC
www.gbhcpas.com
Houston, Texas
March 11, 2016